| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.41 | 0.007 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |